The global respiratory oxygen delivery devices market size is expected to reach USD 21.73 billion by 2030, registering a CAGR of 7.9% from 2023 to 2030, according to a new study by Grand View Research, Inc. The market encompasses diverse medical equipment designed to administer oxygen therapy and aid in respiratory support. These devices are crucial for individuals with various respiratory conditions, ranging from chronic obstructive pulmonary disease (COPD) and asthma to acute situations like COVID-19. The market’s growth is primarily driven by factors, such as the increasing prevalence of respiratory disorders, the growing aging global population, technological advancements leading to more efficient & user-friendly devices, rising awareness about respiratory health, and increasing government funding, which highlighted the importance of adequate respiratory care and oxygen therapy.
For instance, in June 2022, The U.S. Agency for International Development (USAID) progressed with its previously announced USD 50 million initiative to enhance worldwide access to medical oxygen. The agency's efforts included commitments to enhance healthcare infrastructure, particularly establishing and upgrading facilities capable of supporting bulk liquid oxygen in 50 locations globally. USAID's estimates indicated that this investment would provide medical oxygen across more than 20,000 beds, potentially saving the lives of hundreds of thousands of patients annually. The investment addresses a crucial aspect of respiratory care, particularly in regions with limited resources and healthcare infrastructure. Improved access to medical oxygen can increase demand for oxygen delivery devices. As healthcare facilities in these regions are reinforced and equipped to provide life-saving oxygen therapy, the product demand is likely to increase, thereby positively impacting the market growth.
Request a free sample copy or view report summary: Respiratory Oxygen Delivery Devices Market Report
The market growth is attributed to the increasing prevalence of respiratory diseases, such as asthma, COPD, etc., and the rising global geriatric population are major factors driving the market’s growth
The oxygen masks segment accounted for the largest revenue share of 35.96% in 2022
The hospitals segment dominated the market with a revenue share of 51.76% in 2022 and is expected to continue its dominance with the fastest CAGR of 8.0% from 2023 to 2030
Asia Pacific dominated the market with a revenue share of 42.40% in 2022 and is expected to continue its dominance over the forecast period
The market growth in this region can be attributed to the presence of highly populated countries, such as China and India, the availability of the latest technologies, and product launches
Grand View Research has segmented the global respiratory oxygen delivery devices market on the basis of product, end-use, and region:
Respiratory Oxygen Delivery Devices Product Outlook (Revenue, USD Million, 2018 - 2030)
Oxygen Masks
Nasal Cannula
Venturi Masks
Non-rebreather Masks
Bag Valve Masks
CPAP Masks
Others
Respiratory Oxygen Delivery Devices End-use Outlook (Revenue, USD Million, 2018 - 2030)
Hospitals
Outpatient Facilities
Home Care
Respiratory Oxygen Delivery Devices Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Europe
UK
Germany
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
Japan
China
India
Australia
South Korea
Thailand
Latin America
Brazil
Mexico
Argentina
MEA
South Africa
Saudi Arabia
UAE
Kuwait
List of Key Players in the Respiratory Oxygen Delivery Devices Market
GE Healthcare
Koninklijke Philips N.V.
ICU Medical (Smiths Medical)
Invacare Corporation
Medtronic
Fisher & Paykel Healthcare
ResMed
Linde
Mindray
Chart Industries
Drägerwerk AG & Co. KGaA
DeVilbiss Healthcare
"The quality of research they have done for us has been excellent..."